The FDA plans to remove oral phenylephrine as an active ingredient for use in nasal decongestants after a review found it was ineffective [Image: Kelly Sikkema on Unsplash]
Essentials, The US Food and Drug Administration has announced it will remove oral phenylephrine as an active ingredient in nasal decongestants, claiming research , BACK panel - grey
Chemist Warehouse is sponsoring the Young Pharmacist of the Year Award in the 2025 New Zealand Primary Healthcare Awards | He Tohu Mauri Ora. The Chemist Warehouse leadership team explains what it means to be a Stellar Supporter